Skip to main content
. 2023 Feb 17;15(4):1276. doi: 10.3390/cancers15041276

Table 4.

Selection rates of all variables with a selection rate ≥ 50% in at least one of the best-performing mRNA-inclusive pipelines.

Pathological Gleason Sum Score LNI SVI PSA DNAH8 ESM1
Cox 56% 16% 5% 4% 9% 10%
LASSO 60% 9% 64% 34% 55% 29%
Boosted 67% 2% 65% 34% 64% 62%
RSF 86% 88% 31% 62% 59% 50%